1-10 of 10
Alexander Burchardt
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Midostaurin added to chemotherapy and continued single-agent maintenance therapy in acute myeloid leukemia with FLT3 -ITD

Clinical Trials & Observations
Richard F. Schlenk, Daniela Weber, Walter Fiedler, Helmut R. Salih, Gerald Wulf, Hans Salwender, Thomas Schroeder, Thomas Kindler, Michael Lübbert, Dominik Wolf, Jörg Westermann, Doris Kraemer, Katharina S. Götze, Heinz-August Horst, Jürgen Krauter, Michael Girschikofsky, Mark Ringhoffer, Thomas Südhoff, Gerhard Held, Hans-Günter Derigs, Roland Schroers, Richard Greil, Martin Grießhammer, Elisabeth Lange, Alexander Burchardt, Uwe Martens, Bernd Hertenstein, Lore Marretta, Michael Heuser, Felicitas Thol, Verena I. Gaidzik, Wolfgang Herr, Julia Krzykalla, Axel Benner, Konstanze Döhner, Arnold Ganser, Peter Paschka, Hartmut Döhner
Journal: Blood
Blood (2019) 133 (8): 840–851.
https://doi.org/10.1182/blood-2018-08-869453
Published: 2019
Includes: Supplemental data
Journal Articles

Bendamustine Plus Rituximab (B-R) Versus CHOP Plus Rituximab (CHOP-R) As First-Line Treatment in Patients with Indolent and Mantle Cell Lymphomas (MCL) – 7 Year Updated Results from the StiL NHL1 Study

Mathias J. Rummel, MD, Georg Maschmeyer, MD, Arnold Ganser, Andrea Heider, PhD, Ulrich von Grünhagen, MD PhD, Christoph Losem, Gerhard Heil, MD, Manfred Welslau, Christina Balser, MD, Ulrich Kaiser, MD, Eckhart Weidmann, Heinz Dürk, MD, Hans Peter Böck, Martina Beate Stauch, MD, Jürgen Barth, Wolfgang Blau, MD, Alexander Burchardt, MD, Frank Kauff, PhD, Axel Hinke, PhD, Wolfram Brugger, MD
Journal: Blood
Blood (2014) 124 (21): 4407.
https://doi.org/10.1182/blood.V124.21.4407.4407
Published: 2014
Journal Articles

Bendamustine Plus Rituximab Followed By Rituximab Maintenance for Patients with Untreated Advanced Follicular Lymphomas. Results from the StiL NHL 7-2008 Trial (MAINTAIN trial) (ClinicalTrials.gov Identifier: NCT00877214)

Mathias J. Rummel, MD, Andreas Viardot, Richard Greil, MD, Bernd Hertenstein, MD, Christian Lerchenmüller, MD, Arnold Ganser, Manfred Reeb, MD, Ulrich Kaiser, MD, Christina Balser, MD, Georg Maschmeyer, MD, Heinz Dürk, MD, Georg Schliesser, MD, Tobias Gaska, MD, Jan Dürig, MD, Axel C. Matzdorff, MD, Rudolf Weide, MD, Axel Hinke, PhD, Wolfgang Blau, MD, Alexander Burchardt, MD, Frank Kauff, PhD, Jürgen Barth, Wolfram Brugger, MD
Journal: Blood
Blood (2014) 124 (21): 3052.
https://doi.org/10.1182/blood.V124.21.3052.3052
Published: 2014
Journal Articles

Bendamustine Plus Rituximab Versus Fludarabine Plus Rituximab in Patients with Relapsed Follicular, Indolent, or Mantle Cell Lymphomas – 8-Year Follow-up Results of the Randomized Phase III Study NHL 2-2003 on Behalf of the StiL (Study Group Indolent Lymphomas, Germany)

Mathias J. Rummel, MD, Christina Balser, MD, Ulrich Kaiser, MD, Hans Peter Böck, Martina Beate Stauch, MD, Andrea Heider, PhD, Manfred Welslau, Christoph Losem, Eckhart Weidmann, Wolfgang Blau, MD, Alexander Burchardt, MD, Jürgen Barth, Frank Kauff, PhD, Axel Hinke, PhD, Wolfram Brugger, MD
Journal: Blood
Blood (2014) 124 (21): 145.
https://doi.org/10.1182/blood.V124.21.145.145
Published: 2014
Journal Articles

Factor XIII Deficiency in Patients with Acute Leukemia: One out of Three Is Presenting with Deficiency

Elisabetta Vagge, MD, Christian Dornes, Maisun Abu Samra, Wolfgang Blau, MD, Mathias J Rummel, MD, Alexander Burchardt
Journal: Blood
Blood (2014) 124 (21): 1528.
https://doi.org/10.1182/blood.V124.21.1528.1528
Published: 2014
Journal Articles

Investigation Of Fresh Tissue and Effusion Samples From Immunocompromised Hematologic Patients Suspected For Invasive Fungal Infection With An Aspergillus- specific PCR Is a Promising Tool For Identifying Invasive Aspergillosis

Mark Reinwald, MD, Birgit Spiess, PhD, Werner J. Heinz, MD, Claus Peter Heussel, MD, Hartmut Bertz, MD, Oliver A. Cornely, Prof., MD, Joachim Hahn, MD, Thomas Lehrnbecher, MD, Michael Kiehl, MD, Hans Jürgen Laws, Hans-Heinrich Wolf, MD, Rainer Schwerdtfeger, MD, Beate Schultheis, MD, Alexander Burchardt, MD, Michael Klein, MD, Matthias Dürken, MD, Bernd Claus, MD, Frank Schlegel, MD, Margit Hummel, MD, Wolf-Karsten Hofmann, MD, Dieter Buchheidt, MD
Journal: Blood
Blood (2013) 122 (21): 4552.
https://doi.org/10.1182/blood.V122.21.4552.4552
Published: 2013
Journal Articles

Impact Of The Pretreatment Characteristics As Well As Cyto- and Molecular-Genetic Profile On Outcome After Relapse In Acute Myeloid Leukemia

Richard F. Schlenk, MD, Peter Frech, Sabine Kayser, MD, Daniela Späth, MSc, Peter Brossart, MD, Heinz-August Horst, MD, Doris M Kraemer, M.D., Gerhard Held, Mark Ringhoffer, MD, Alexander Burchardt, M.D., Andrea Kündgen, M.D., Katharina Goetze, MD, David Nachbaur, MD, Thomas Kindler, MD, Michael Lübbert, MD, Helmut R. Salih, MD, Hans Salwender, MD, Gerald Wulf, MD, Elisabeth Koller, MD, Mohammed Wattad, MD, Walter Fiedler, MD, Stephan Kremers, MD, Heinz Kirchen, MD, Bernd Hertenstein, MD, Peter Paschka, MD, Verena I. Gaidzik, MD, Veronica Teleanu, MD, Michael Heuser, MD, Felicitas Thol, MD, Arnold Ganser, MD, Konstanze Döhner, MD, Hartmut Döhner, MD
Journal: Blood
Blood (2013) 122 (21): 830.
https://doi.org/10.1182/blood.V122.21.830.830
Published: 2013
Journal Articles

Safety and Efficacy of a Six Month Full Dose Lenalidomide Consolidation Treatment After First-Line High-Dose Therapy in Patients with Multiple Myeloma

Roland Fenk, MD, Julia Baier, Aristoteles Giagounidis, MD, Mathias J. Rummel, MD, Nicolaus Kröger, Tobias Strapatsas, MD, Ariane Dienst, Esther Zipperer, MD, Kathrin Nachtkamp, MD, Alexander Burchardt, MD, Thomas Schroeder, MD, Lars Galonska, MD, Norbert Gattermann, MD, Rainer Haas, MD, Guido Kobbe, MD
Journal: Blood
Blood (2012) 120 (21): 1982.
https://doi.org/10.1182/blood.V120.21.1982.1982
Published: 2012
Journal Articles

Peripheral Blood Stem Cell Mobilization After Bendamustine Containing Chemotherapy in Indolent Lymphomas Is Possible. Results From the Phase III Study of B-R Vs. CHOP-R (NHL 1-2003 trial) of the StiL (Study group indolent Lymphomas, Germany).

Christoph Alexander Burchardt, Wolfram Brugger, Georg Maschmeyer, Dorothea Kofahl-Krause, Lars Fischer, Fritz Roller, Juergen Barth, Mathias J Rummel
Journal: Blood
Blood (2009) 114 (22): 2679.
https://doi.org/10.1182/blood.V114.22.2679.2679
Published: 2009
Journal Articles

Campath-1H-Based Reduced-Intensity Conditioning Followed by Allogeneic Blood Stem-Cell Transplantation and Preemptive CD8-Depleted Donor Lymphocyte Infusions.

Ralf G. Meyer, MD, Daniela Wehler, MD, Thomas C. Wehler, MD, Cedrik M. Britten, MD, Alexander Burchardt, MD, Udo Hartwig, PhD, Christoph Huber, MD, Karin Kolbe, MD, Wolfgang Herr, MD
Journal: Blood
Blood (2004) 104 (11): 5069.
https://doi.org/10.1182/blood.V104.11.5069.5069
Published: 2004